Guangdong Biolight Meditech financials at a glance

+ Portfolio

The revenue of Guangdong Biolight Meditech is reported as 0.59431 billion Yuan Renminbi in the fiscal year 2016. The earnings were 0 Yuan Renminbi per share in 2016, which was 26.67 lower than 2014. And about 0.00681 billion Yuan Renminbi are reported as free cash flow in the financials of Guangdong Biolight Meditech 2016. No dividends were paid to the shareholders of the Guangdong Biolight Meditech stock SZSE:300246 in the financial year 2016.

Forecast

Financials

Year	Year	TTM	2015	2014	2012	2011
Rev.	Revenue	N/A	¥0.00M	¥288.99M	¥0.00M	¥158.10M
GM %	Gross Margin %	32.69%	39.28%	44.69%	47.45%	47.64%
OM	Operating Margin	5.04%	7.85%	11.38%	15.47%	18.80%
EPS	Earnings Per Share	¥0.29	¥0.11	¥0.15	¥0.15	¥0.17
Div.	Dividends	N/A	¥0.00	¥0.03	¥0.00	¥0.00
PR %	Payout Ratio %	0	0	20.00%	0	0
Sha.	Shares	N/AM	219.13M	219.13M	219.13M	219.13M
OCF	Operating Cash Flow	N/A	¥0.00M	¥0.00M	¥0.00M	¥29.06M
FCF	Free Cash Flow	N/A	¥0.00M	¥0.00M	¥0.00M	¥16.20M
FCFS	Free Cash Flow Per Share	¥-0.36	¥-0.00	¥-0.09	¥0.16	¥0.17

Guangdong Biolight Meditech financials at a glance

Financials

Discover